GEMCITABINE Side Effects

6958664-4 | Neutrophil Count Decreased
on Aug 30, 2010 Female patient from UNITED STATES , 50 years of age, weighting 212.7 lb, was diagnosed with ovarian cancer and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: neutrophil count decreased. Gemcitabine dosage: 1000mg/m2 D1 + D15 Q28days Iv. During the same period patient was treated with CARBOPLATIN (Auc-3 D1 + D15 Q28days Ic) (View Carboplatin Review and Carboplatin Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

6957750-2 | Ascites, Peripheral Ischaemia, Pulmonary Embolism
Patient was taking Gemcitabine (View Usage). Patient had the following side effects: ascites, peripheral ischaemia, pulmonary embolism (What is pulmonary embolism?) on Aug 23, 2010 from FRANCE Additional patient health information: Male patient , 84 years of age, . Gemcitabine dosage: .

6955540-8 | Arrhythmia, Asthenia, Failure To Thrive, Fatigue, Insomnia, Pneumonia, Pulmonary Embolism, Pyrexia, Renal Tubular Necrosis
Adverse event was reported on Aug 26, 2010 by a Male patient taking Gemcitabine (View Usage) (Dosage: 1000mg/m2 Every 2 Weeks Iv Drip) was diagnosed with pancreatic carcinoma and. Location: UNITED STATES , weighting 107.8 lb, After Gemcitabine was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), asthenia, failure to thrive, fatigue, insomnia, pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), pyrexia, renal tubular necrosis. During the same period patient was treated with CAPECITABINE (1000 Mg/m2 Bid Days 1-7/14 Po) (View Capecitabine Review and Capecitabine Label ), FENTANYL 75 (View Fentanyl-75 Review and Fentanyl-75 Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ZOFRAN (View Zofran Review and Zofran Label ), TYLENOL W/ CODEINE NO. 3 (View Tylenol W/ Codeine No. 3 Review and Tylenol W/ Codeine No. 3 Label ). Patient was hospitalized.

6945887-3 | Vasculitis Cerebral
on Aug 09, 2010 Female patient from GERMANY , 50 years of age, was diagnosed with genitourinary tract neoplasm and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: vasculitis cerebral. Gemcitabine dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ).


6929906-6 | Bile Duct Stenosis
on Aug 12, 2010 Female patient from GERMANY , weighting 109.8 lb, was diagnosed with lung adenocarcinoma and was treated with Gemcitabine (View Usage). Patient had the following side effects: bile duct stenosis. Gemcitabine dosage: . Patient was hospitalized.

6924284-0 | Muscular Weakness
Patient was taking Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: muscular weakness on Aug 12, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 202.8 lb, was diagnosed with metastases to liver, pancreatic carcinoma and. Gemcitabine dosage: . Patient was hospitalized.

6924194-9 | Leukopenia, Neutropenia
Adverse event was reported on Aug 12, 2010 by a Female patient taking Gemcitabine (View Usage) (Dosage: 1620mg Q 15 Days Iv Drip) was diagnosed with ovarian cancer and. Location: UNITED STATES , weighting 121.7 lb, Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia. During the same period patient was treated with CARBOPLATIN (311mg Q 15 Days Iv Drip) (View Carboplatin Review and Carboplatin Label ).

6922971-1 | Blood Creatine Phosphokinase, Rhabdomyolysis
on Aug 06, 2010 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine (View Usage). Patient had the following side effects: blood creatine phosphokinase, rhabdomyolysis. Gemcitabine dosage: . During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ).

6885303-3 | Cough, Pneumonia, Pyrexia
on Jul 29, 2010 Male patient from UNITED STATES , 54 years of age, weighting 271.2 lb, was diagnosed with liposarcoma and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: cough, pneumonia (What is pneumonia?), pyrexia. Gemcitabine dosage: 506mg/m2, 21 Day Int, Iv. During the same period patient was treated with DOCETAXEL (56mg/m2, 21 Day Int, Iv) (View Docetaxel Review and Docetaxel Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ), VICODIN (View Vicodin Review and Vicodin Label ), ATIVAN (View Ativan Review and Ativan Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6883403-5 | Capillary Leak Syndrome, Fatigue
Patient was taking Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: capillary leak syndrome, fatigue on Jul 20, 2010 from GERMANY Additional patient health information: Female patient , weighting 131.6 lb, was diagnosed with adenocarcinoma, metastases to liver, pancreatic disorder and. Gemcitabine dosage: = 1264 Mg Once (only 1st Cycle). During the same period patient was treated with PANCREATIN (75.000 Ie) (View Pancreatin Review and Pancreatin Label ).

6881449-4 | Blood Pressure Increased, Deep Vein Thrombosis, Electrocardiogram St Segment Depression, Failure To Thrive, Malignant Neoplasm Progression, Malnutrition, Oedema Peripheral, Sinus Tachycardia
Adverse event was reported on Jul 28, 2010 by a Female patient taking Gemcitabine (View Usage) (Dosage: 1000 Mg/m2 Weekly X2 Iv) was diagnosed with pancreatic carcinoma metastatic and. Location: UNITED STATES , weighting 112.2 lb, Patient had the following side effects: blood pressure increased, deep vein thrombosis (What is deep vein thrombosis?), electrocardiogram st segment depression, failure to thrive, malignant neoplasm progression, malnutrition, oedema peripheral, sinus tachycardia. During the same period patient was treated with ERLOTINIB HYDROCHLORIDE (100 Mg Qd X 21 Doses) (View Erlotinib Hydrochloride Review and Erlotinib Hydrochloride Label ), MORPHINE (View Morphine Review and Morphine Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6877171-0 | Face Oedema, Hypersensitivity, Lip Oedema
on Jul 27, 2010 Male patient from UNITED STATES , weighting 153.0 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: face oedema, hypersensitivity, lip oedema. Gemcitabine dosage: 1000mg/m2 Every 2 Weeks Iv Drip. During the same period patient was treated with CAPECITABINE (1000mg/m2 Bid Days 1-7/14 Po) (View Capecitabine Review and Capecitabine Label ).

6683584-2 | Hepatitis, Malaise
on Mar 31, 2010 Female patient from UNITED KINGDOM , 64 years of age, was diagnosed with non-small cell lung cancer metastatic and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis (What is hepatitis?), malaise. Gemcitabine dosage: (1250 Mg/m2), Intravenous. During the same period patient was treated with CARBOPLATIN ((430 Mg)) (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METACLOPRAMIDE (METOCLOPRAMIDE HYDROCHLORIDE) (METOCLOPRAMIDE HYDROCHL (View Metaclopramide (metoclopramide Hydrochloride) (metoclopramide Hydrochl Review and Metaclopramide (metoclopramide Hydrochloride) (metoclopramide Hydrochl Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), BRUFEN (IBUPROFEN) (IBUPROFEN) (View Brufen (ibuprofen) (ibuprofen) Review and Brufen (ibuprofen) (ibuprofen) Label ), PARACETAMOL (PARACETAMOL) (PARACETAMOL) (View Paracetamol (paracetamol) (paracetamol) Review and Paracetamol (paracetamol) (paracetamol) Label ), TRAMADOL HYDROCHLORIDE (TRAMADOL HYDROCHLORIDE) (TRAMADOL HYDROCHLORID (View Tramadol Hydrochloride (tramadol Hydrochloride) (tramadol Hydrochlorid Review and Tramadol Hydrochloride (tramadol Hydrochloride) (tramadol Hydrochlorid Label ). Patient was hospitalized.

6624077-8 | Disease Recurrence, Hepatitis B, International Normalised Ratio Increased
Patient was taking Gemcitabine (View Usage). Patient had the following side effects: disease recurrence, hepatitis b (What is hepatitis b?), international normalised ratio increased on Feb 16, 2010 from TURKEY Additional patient health information: Male patient , 53 years of age, was diagnosed with lung neoplasm malignant and. Gemcitabine dosage: .

6600904-5 | Abdominal Pain, Haemolytic Uraemic Syndrome, Hypertension, Renal Failure Acute, Thrombotic Thrombocytopenic Purpura
Adverse event was reported on Feb 24, 2010 by a Male patient taking Gemcitabine (View Usage) (Dosage: (17 Cycles)) was diagnosed with pancreatic carcinoma and. Location: UNITED STATES , 66 years of age, weighting 206.0 lb, After Gemcitabine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), haemolytic uraemic syndrome, hypertension, renal failure acute, thrombotic thrombocytopenic purpura. Patient was hospitalized.

6584616-2 | Haemoglobin Decreased, Neutrophil Count Decreased, Thrombocytopenia, White Blood Cell Count Decreased
on Feb 13, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, neutrophil count decreased, thrombocytopenia, white blood cell count decreased. Gemcitabine dosage: 1350mg. During the same period patient was treated with ALIMTA (450mg) (View Alimta Review and Alimta Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6582669-9 | Blood Creatinine Increased, Blood Urea Increased
on Feb 12, 2010 Male patient from UNITED STATES , 59 years of age, weighting 231.0 lb, was treated with Gemcitabine (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased. Gemcitabine dosage: 200 Mg Once Iv. Patient was hospitalized.

6578994-8 | Febrile Infection, Pneumonia
Patient was taking Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: febrile infection, pneumonia (What is pneumonia?) on Feb 05, 2010 from Additional patient health information: Male patient , weighting 155.4 lb, was diagnosed with lung adenocarcinoma and. Gemcitabine dosage: 1700 Mg Per Week. Patient was hospitalized.

6571105-4 | Pancytopenia
Adverse event was reported on Feb 02, 2010 by a Male patient taking Gemcitabine (View Usage) (Dosage: 1552-1560 Mg Qweek Iv) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: UNITED STATES , 83 years of age, weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: pancytopenia. Patient was hospitalized.

6571104-2 | Pancytopenia
on Feb 02, 2010 Male patient from UNITED STATES , 83 years of age, weighting 160.9 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). Patient had the following side effects: pancytopenia. Gemcitabine dosage: 1528-1568 Mg Qweek Iv. Patient was hospitalized.

6571055-3 | Cardiomegaly, Cerebral Infarction, Culture Urine Positive, Pancytopenia, Sepsis, Urinary Tract Infection
on Feb 02, 2010 Male patient from UNITED STATES , 83 years of age, weighting 160.9 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: cardiomegaly, cerebral infarction, culture urine positive, pancytopenia, sepsis (What is sepsis?), urinary tract infection (What is urinary tract infection?). Gemcitabine dosage: 1568-1600 Mg Qweek Iv. Patient was hospitalized.

6569925-5 | Pancytopenia, Renal Failure Acute, Thrombocytopenia, Vaginal Haemorrhage
Patient was taking Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia, renal failure acute, thrombocytopenia, vaginal haemorrhage on Feb 02, 2010 from UNITED STATES Additional patient health information: Female patient , 74 years of age, weighting 134.0 lb, was diagnosed with pancreatic carcinoma and. Gemcitabine dosage: 750mg/m2 Every 14 Days Iv. Patient was hospitalized.

6565352-5 | Erysipelas, Oedema Peripheral, Pain In Extremity
Adverse event was reported on Jan 25, 2010 by a Female patient taking Gemcitabine (View Usage) (Dosage: ) was diagnosed with lung adenocarcinoma and. Location: GERMANY , weighting 200.6 lb, Patient had the following side effects: erysipelas, oedema peripheral, pain in extremity. Patient was hospitalized.

6547278-6 | Cholangitis Suppurative, Jaundice Cholestatic, Pyrexia
on Jan 15, 2010 Male patient from GERMANY , weighting 198.4 lb, was diagnosed with carcinoid tumour of the pancreas and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: cholangitis suppurative, jaundice cholestatic, pyrexia. Gemcitabine dosage: . Patient was hospitalized.

6547241-5 | Dyspnoea, Pneumonia
on Jan 15, 2010 Female patient from , weighting 110.2 lb, was diagnosed with lung adenocarcinoma and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, pneumonia (What is pneumonia?). Gemcitabine dosage: . Patient was hospitalized.

6543634-0 | Confusional State, Dyskinesia, Incorrect Dose Administered, Mental Status Changes, Nausea, Pain
Patient was taking Gemcitabine (View Usage). Patient had the following side effects: confusional state, dyskinesia, incorrect dose administered, mental status changes, nausea (What is nausea?), pain (What is pain?) on Jan 19, 2010 from UNITED STATES Additional patient health information: Male patient , 68 years of age, weighting 163.4 lb, was diagnosed with pancreatic carcinoma and. Gemcitabine dosage: Gemcitebine Q 2 Wks Iv. During the same period patient was treated with OXALIPLATIN (Oxaliplatin Q2 Wek Iv) (View Oxaliplatin Review and Oxaliplatin Label ), ERLOTINIB (Erlotinib 5mg Oral) (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6543632-7 | Asthenia, Confusional State
Adverse event was reported on Jan 19, 2010 by a Male patient taking Gemcitabine (View Usage) (Dosage: Gemcitebine Q 2 Wks Iv) was diagnosed with pancreatic carcinoma and. Location: UNITED STATES , 68 years of age, weighting 163.4 lb, After Gemcitabine was administered, patient had the following side effects: asthenia, confusional state. During the same period patient was treated with OXALIPLATIN (Oxaliplatin Q 2 Wks Iv) (View Oxaliplatin Review and Oxaliplatin Label ), ERLOTINIB (Erlotinib 5 Mg Po Daily) (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6538525-5 | Dyskinesia, Incorrect Dose Administered, Mental Status Changes, Nausea
on Jan 13, 2010 Male patient from UNITED STATES , 68 years of age, weighting 163.4 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: dyskinesia, incorrect dose administered, mental status changes, nausea (What is nausea?). Gemcitabine dosage: Gemcitibine Q 2 Wks Iv. During the same period patient was treated with OXALIPLATIN (Oxaliplatin Q 2 Wks Iv) (View Oxaliplatin Review and Oxaliplatin Label ), ERLOTINIB (Erlotinib 5mg Oral) (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6531715-7 | Blood Creatine Phosphokinase Increased, Oedema Peripheral, Pain In Extremity
on Jan 07, 2010 Female patient from UNITED STATES , 58 years of age, weighting 224.9 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, oedema peripheral, pain in extremity. Gemcitabine dosage: 1000 Iv Day 1,8,15. During the same period patient was treated with OXALIPLATIN (85mg/m2 Iv Day 1. 15) (View Oxaliplatin Review and Oxaliplatin Label ), LOTREL (View Lotrel Review and Lotrel Label ), ZETIA (View Zetia Review and Zetia Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LASIX (View Lasix Review and Lasix Label ), LOZOL (View Lozol Review and Lozol Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ). Patient was hospitalized.

6527864-X | Pneumonia
Patient was taking Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: pneumonia (What is pneumonia?) on Dec 28, 2009 from GERMANY Additional patient health information: Female patient , weighting 165.3 lb, was diagnosed with lung adenocarcinoma, metastases to bone, metastases to adrenals and. Gemcitabine dosage: . Patient was hospitalized.

6509765-6 | Haemoglobin Decreased, Neutrophil Count Abnormal, Thrombocytopenia, White Blood Cell Count Decreased
Adverse event was reported on Dec 21, 2009 by a Female patient taking Gemcitabine (View Usage) (Dosage: 1350mg) was diagnosed with pancreatic carcinoma metastatic and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, neutrophil count abnormal, thrombocytopenia, white blood cell count decreased. During the same period patient was treated with ALIMTA (450mg) (View Alimta Review and Alimta Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6509764-4 | Acute Prerenal Failure, Hypovolaemia, Oedema Peripheral, Pancytopenia
on Dec 21, 2009 Female patient from UNITED STATES , 76 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Gemcitabine (View Usage). Patient had the following side effects: acute prerenal failure, hypovolaemia, oedema peripheral, pancytopenia. Gemcitabine dosage: 2700mg. During the same period patient was treated with ALIMTA (900mg) (View Alimta Review and Alimta Label ). Patient was hospitalized.

6493243-7 | Haemolytic Anaemia, Renal Failure, Thrombotic Thrombocytopenic Purpura
on Dec 11, 2009 Female patient from UNITED STATES , weighting 124.6 lb, was diagnosed with malignant neoplasm of ampulla of vater and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: haemolytic anaemia, renal failure, thrombotic thrombocytopenic purpura. Gemcitabine dosage: 1230 Mg On Day #1 And A Day #8 Cycle Q21days Iv. Patient was hospitalized.

6476948-3 | Pulmonary Oedema
Patient was taking Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema on Dec 03, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with pancreatic carcinoma and. Gemcitabine dosage: . During the same period patient was treated with ABRAXANE (View Abraxane Review and Abraxane Label ). Patient was hospitalized.

6445728-7 | Abdominal Pain, Nausea
Adverse event was reported on Nov 18, 2009 by a Female patient taking Gemcitabine (View Usage) (Dosage: 1000mg/ml, Iv) was diagnosed with pancreatic carcinoma and. Location: CANADA , 54 years of age, weighting 123.5 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?). During the same period patient was treated with OXALIPLATIN (85mg/ml, Iv) (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

6427908-X | Abdominal Pain, Back Pain, Bacterial Test Positive, Chills, Klebsiella Infection, Neutropenia, Sepsis
on Nov 04, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), bacterial test positive, chills, klebsiella infection, neutropenia, sepsis (What is sepsis?). Gemcitabine dosage: 2000 Mg Other Iv. During the same period patient was treated with CARBOPLATIN (700 Mg Other Iv) (View Carboplatin Review and Carboplatin Label ). Patient was hospitalized.

6425299-1 | Oedema Peripheral
on Nov 02, 2009 Male patient from UNITED STATES , 70 years of age, weighting 214.3 lb, was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral. Gemcitabine dosage: 2350 Mg Qweek Iv.

6407539-8 | Atrial Fibrillation
Patient was taking Gemcitabine (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?) on Oct 12, 2009 from FRANCE Additional patient health information: Female patient , 82 years of age, was diagnosed with t-cell lymphoma and. Gemcitabine dosage: .

6390536-9 | Cardio-respiratory Arrest, Deep Vein Thrombosis, Fatigue, Metastatic Carcinoma Of The Bladder, Pulmonary Embolism
Adverse event was reported on Oct 02, 2009 by a Male patient taking Gemcitabine (View Usage) (Dosage: Days 1,8 And 15 Mg/m**2 Cyc Iv) was diagnosed with bladder cancer (What is bladder cancer?) and. Location: UNITED STATES , 49 years of age, weighting 140.7 lb, After Gemcitabine was administered, patient had the following side effects: cardio-respiratory arrest, deep vein thrombosis (What is deep vein thrombosis?), fatigue, metastatic carcinoma of the bladder, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CISPLATIN (139 Mg/day Iv) (View Cisplatin Review and Cisplatin Label ), PERCOCET (View Percocet Review and Percocet Label ), DOXYCYCLINE HYCLATE (View Doxycycline Hyclate Review and Doxycycline Hyclate Label ). Patient was hospitalized.

6390500-X | Body Temperature Increased, Chapped Lips, Chills, Diarrhoea, Epistaxis, Fatigue, Haematuria, Neutrophil Count Decreased, Oropharyngeal Pain
on Oct 05, 2009 Male patient from UNITED STATES , 50 years of age, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, chapped lips, chills, diarrhoea, epistaxis, fatigue, haematuria, neutrophil count decreased, oropharyngeal pain. Gemcitabine dosage: 2000 Mg Other Iv. Patient was hospitalized.

6380724-X | Pericardial Effusion
on Sep 17, 2009 Female patient from UNITED STATES , weighting 203.0 lb, was diagnosed with renal cell carcinoma and was treated with Gemcitabine (View Usage). Patient had the following side effects: pericardial effusion. Gemcitabine dosage: 600 Mg/m2, On Day1 And Day8. During the same period patient was treated with SUNITINIB MALATE (25 Mg, Daily, D1-14) (View Sunitinib Malate Review and Sunitinib Malate Label ), XANAX (Unk) (View Xanax Review and Xanax Label ), LIPITOR (Unk) (View Lipitor Review and Lipitor Label ), CITALOPRAM (Unk) (View Citalopram Review and Citalopram Label ), CLONIDINE (Unk) (View Clonidine Review and Clonidine Label ), IMODIUM (Unk) (View Imodium Review and Imodium Label ), LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6375178-3 | Blood Pressure Systolic Increased, Cardiac Disorder, Electrocardiogram St Segment Elevation, Myocardial Infarction, Myocardial Ischaemia, Sinus Tachycardia
Patient was taking Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: blood pressure systolic increased, cardiac disorder, electrocardiogram st segment elevation, myocardial infarction, myocardial ischaemia, sinus tachycardia on Sep 22, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 106.3 lb, . Gemcitabine dosage: . During the same period patient was treated with OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), ALPRAXOLAM (View Alpraxolam Review and Alpraxolam Label ), DRONABINOL (View Dronabinol Review and Dronabinol Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MIRALAX (View Miralax Review and Miralax Label ), COMPAZINE (View Compazine Review and Compazine Label ), SENOKOT (View Senokot Review and Senokot Label ). Patient was hospitalized.

6371367-2 | Diverticulitis
Adverse event was reported on Sep 18, 2009 by a Female patient taking Gemcitabine (View Usage) (Dosage: 360 Mg, Every 2 Wks, Iv) was diagnosed with pancreatic carcinoma metastatic and. Location: UNITED STATES , 53 years of age, weighting 111.4 lb, Patient experienced the following unwanted or unexpected effects: diverticulitis. During the same period patient was treated with FLUOROURACIL (3600 Mg, Every 3 Wks, Iv) (View Fluorouracil Review and Fluorouracil Label ), BEVACIZUMAB (550mg, Every 2 Wks, Iv) (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6368700-4 | Platelet Count Abnormal
on Sep 17, 2009 Male patient from UNITED STATES , 49 years of age, weighting 148.0 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). Patient had the following side effects: platelet count abnormal. Gemcitabine dosage: 1000 Mg/m2 3 Wks On 1 Wk Off Iv.

6355849-5 | Cardio-respiratory Arrest, Deep Vein Thrombosis, Malignant Neoplasm Progression, Metastatic Carcinoma Of The Bladder, Pulmonary Embolism
on Sep 11, 2009 Male patient from UNITED STATES , 49 years of age, weighting 140.7 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: cardio-respiratory arrest, deep vein thrombosis (What is deep vein thrombosis?), malignant neoplasm progression, metastatic carcinoma of the bladder, pulmonary embolism (What is pulmonary embolism?). Gemcitabine dosage: Days 1,8 And 15 Mg/m**2 Cyc Iv. During the same period patient was treated with CISPLATIN (132 Mg/day Iv) (View Cisplatin Review and Cisplatin Label ), PERCOCET (View Percocet Review and Percocet Label ), DOXYCYCLINE HYCLATE (View Doxycycline Hyclate Review and Doxycycline Hyclate Label ). Patient was hospitalized.

6317779-4 | Ascites, Blood Albumin Decreased, Blood Bilirubin Increased, Haematocrit Decreased, Haemoglobin Decreased, Inflammation, Klebsiella Infection, Pleural Effusion, White Blood Cell Count Decreased
Patient was taking Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, blood albumin decreased, blood bilirubin increased, haematocrit decreased, haemoglobin decreased, inflammation, klebsiella infection, pleural effusion, white blood cell count decreased on Aug 20, 2009 from UNITED STATES Additional patient health information: Male patient , 61 years of age, was diagnosed with pancreatic carcinoma and. Gemcitabine dosage: 1000mg/m2 Every 2 Weeks Iv Drip. During the same period patient was treated with CAPECITABINE (1000mg/m2 Bid Days 1-7/14 Po) (View Capecitabine Review and Capecitabine Label ). Patient was hospitalized.

6316146-7 | Abdominal Pain, Nausea
Adverse event was reported on Aug 19, 2009 by a Male patient taking Gemcitabine (View Usage) (Dosage: 750 Mg/m2 Iv Weeks 1 + 2) was diagnosed with pancreatic carcinoma and. Location: UNITED STATES , weighting 113.6 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?). During the same period patient was treated with ERLOTINIB (25 Mg Fixed Po Qd X 14 D) (View Erlotinib Review and Erlotinib Label ). Patient was hospitalized.

6316145-5 | Abdominal Pain, Breakthrough Pain, Gastrointestinal Motility Disorder, Impaired Gastric Emptying, Nausea
on Aug 19, 2009 Male patient from UNITED STATES , weighting 113.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemcitabine (View Usage). After Gemcitabine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), breakthrough pain, gastrointestinal motility disorder, impaired gastric emptying, nausea (What is nausea?). Gemcitabine dosage: 750 Mg/m2 Iv Weeks 1 + 2. During the same period patient was treated with ERLOTINIB (25 Mg Fixed Po Qd X 14 D) (View Erlotinib Review and Erlotinib Label ), FENTYNAL PATCH (View Fentynal Patch Review and Fentynal Patch Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ). Patient was hospitalized.

6316141-8 | Bacterial Infection, Blood Creatinine Increased, Blood Culture Positive, Cardiac Arrest, Cardiomegaly, Dilatation Atrial, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased
on Aug 19, 2009 Male patient from ISRAEL , 81 years of age, weighting 182.8 lb, was diagnosed with bladder cancer (What is bladder cancer?) and was treated with Gemcitabine (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial infection (What is bacterial infection?), blood creatinine increased, blood culture positive, cardiac arrest (What is cardiac arrest?), cardiomegaly, dilatation atrial, dilatation ventricular, dyspnoea, ejection fraction decreased. Gemcitabine dosage: 1000 Mg/m2 Days 1,8 And 15 Mg/m**2 Cyc Iv. During the same period patient was treated with CISPLATIN (50 Mg/m**2 Cyc Iv) (View Cisplatin Review and Cisplatin Label ), NORMALOL (View Normalol Review and Normalol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INHIBACE (View Inhibace Review and Inhibace Label ), SETRON (View Setron Review and Setron Label ), TAGAMET (View Tagamet Review and Tagamet Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), EMEND (View Emend Review and Emend Label ).

6314924-1 | Abdominal Pain, Impaired Gastric Emptying, Nausea
Patient was taking Gemcitabine (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), impaired gastric emptying, nausea (What is nausea?) on Aug 18, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 113.6 lb, was diagnosed with pancreatic carcinoma and. Gemcitabine dosage: 750 M/m2 Iv Wooks 1 + 2. During the same period patient was treated with ERLOTINIB (25 Mg Fixed Po Qd X 14 D) (View Erlotinib Review and Erlotinib Label ), FENTYNAL PATCH (View Fentynal Patch Review and Fentynal Patch Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), RADIATION (View Radiation Review and Radiation Label ). Patient was hospitalized.